ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CCCC C4 Therapeutics Inc

4.10
-0.04 (-0.97%)
Jun 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,294,348
Bid Price 3.97
Ask Price 4.10
News -
Day High 4.10

Low
1.06

52 Week Range

High
11.88

Day Low 3.91
Share Name Share Symbol Market Stock Type
C4 Therapeutics Inc CCCC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -0.97% 4.10 16:29:00
Open Price Low Price High Price Close Price Previous Close
4.10 3.91 4.10 4.08 4.14
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
11,994 1,294,348 US$ 4.01 US$ 5,192,756 - 1.06 - 11.88
Last Trade Type Quantity Price Currency
18:59:50 25 US$ 4.0983 USD

C4 Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
279.89M 68.60M - 20.76M -132.49M -1.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

C4 Therapeutics News

Date Time Source News Article
6/11/202415:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/11/202415:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
6/10/202406:41Edgar (US Regulatory)Form 8-K - Current report
6/10/202406:00GlobeNewswire Inc.C4 Therapeutics Appoints Ron Cooper as Chairman of the Board..
5/08/202406:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202406:07Edgar (US Regulatory)Form 8-K - Current report
5/08/202406:00GlobeNewswire Inc.C4 Therapeutics Reports First Quarter 2024 Financial Results..
4/29/202415:01GlobeNewswire Inc.C4 Therapeutics Announces Inducement Grant Under Nasdaq..
4/09/202406:00GlobeNewswire Inc.C4 Therapeutics to Participate in the Stifel 2024 Targeted..
4/08/202407:00GlobeNewswire Inc.C4 Therapeutics Presents New Preclinical Data for CFT1946..
3/08/202418:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202418:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CCCC Message Board. Create One! See More Posts on CCCC Message Board See More Message Board Posts

Historical CCCC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.775.143.914.581,432,767-0.67-14.05%
1 Month5.635.863.914.931,227,176-1.53-27.18%
3 Months8.368.533.916.311,297,833-4.26-50.96%
6 Months4.9511.883.916.713,461,548-0.85-17.17%
1 Year3.3511.881.065.124,742,7460.7522.39%
3 Years37.1951.211.067.011,932,766-33.09-88.98%
5 Years26.6051.211.068.301,640,552-22.50-84.59%

C4 Therapeutics Description

C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Your Recent History

Delayed Upgrade Clock